Edition:
United States

Wockhardt Ltd (WCKH.NS)

WCKH.NS on National Stock Exchange of India

731.05INR
2:18am EDT
Change (% chg)

Rs13.05 (+1.82%)
Prev Close
Rs718.00
Open
Rs721.60
Day's High
Rs734.95
Day's Low
Rs720.00
Volume
526,888
Avg. Vol
1,178,234
52-wk High
Rs1,129.05
52-wk Low
Rs627.20

Latest Key Developments (Source: Significant Developments)

Wockhardt's unit gets FDA nod for piperacillin and tazobactam for injection
Tuesday, 21 Mar 2017 07:49am EDT 

Wockhardt Ltd : Says FDA approved ANDA of piperacillin and tazobactam for injection usp, 40.5 g/vial, pharmacy bulk package submitted by co's unit .ANDA was determined to be therapeutically equivalent to reference listed drug (RLD) Zosyn for injection 40.5g/vial.  Full Article

Wockhardt says HPRA inspected co's Shendra, Aurangabad facility
Tuesday, 7 Mar 2017 07:18am EST 

Wockhardt Ltd : Says HPRA inspected co's Shendra, Aurangabad facility .Says recommended renewal of certificate based on general compliance with principles and guidnelines of good manufacturing practice.  Full Article

Wockhardt Ltd gets USFDA warning letter for co's stepdown unit
Wednesday, 1 Mar 2017 07:11am EST 

Wockhardt Ltd : Says USFDA issued a warning letter to Morton Grove Pharmaceuticals Inc., USA, a stepdown subsidiary of company . Says current portfolio of company will continue to be made available in market . Says new approvals will be withheld till resolution .Says company has already initiated appropriate measures since last several months to address the issues raised by USFDA.  Full Article

Pharmadax signs license contract with Wockhardt
Wednesday, 1 Feb 2017 09:29pm EST 

Pharmadax Inc <4191.TWO> : Says it signed contract with Wockhardt Bio AG, Switzerland, for a blood pressure lowering generic drug product .After the company getting FDA approval, Wockhardt will sell the product in USA and the company will receive milestone payment of $2 million and share profits with Wockhardt.  Full Article

Wockhardt Ltd posts Dec qtr consol loss
Tuesday, 24 Jan 2017 06:05am EST 

Wockhardt Ltd : Wockhardt Ltd - dec quarter consol net loss 539.1 million rupees . Wockhardt Ltd - dec quarter consol net sales 9.96 billion rupees . Wockhardt Ltd - consol net profit in dec quarter last year was 720.4 million rupees as per Ind-AS; consol net sales was 10.75 billion rupees .Wockhardt Ltd says performance during quarter was affected by subdued business in U.S. Market, demonetization in India and continued remediation costs.  Full Article

Wockhardt Ltd approves acquisition of stake in Wockhardt France (Holdings)
Thursday, 10 Nov 2016 08:08am EST 

Wockhardt Ltd :Wockhardt Ltd says approved acquisition of 100% stake in Wockhardt France (Holdings) S.A.S. from Wockhardt Bio AG.  Full Article

Wockhardt says inspection at Chikalthana unit completed without critical observations
Thursday, 29 Sep 2016 02:02am EDT 

Wockhardt Ltd :Inspection of unit at l-1, Chikalthana, Aurangabad by UK MHRA completed without any critical observations.  Full Article

Wockhardt says FDA issues import alert on co's Gujarat API unit
Monday, 8 Aug 2016 02:06am EDT 

Wockhardt Ltd : FDA updated import alert 66-40 on Gujarat API unit;co awaits FDA official communication in matter; co initiated steps to address FDA concerns .  Full Article

Wockhardt says Chikalthana gets EIR clearance
Thursday, 21 Jul 2016 04:49am EDT 

Wockhardt Ltd : Clarifies on news item "chikalthana gets eir clearance with no observations". . Chikalthana, h-14/2 waluj and b-15/2 waluj in maharashtra gets eir with observations .  Full Article

India's Wockhardt March-qtr consol net profit up about 26 pct
Friday, 6 May 2016 07:10am EDT 

Wockhardt Ltd : India's Wockhardt Ltd - March-quarter consol net profit 429 million rupees versus net profit of 340.8 million rupees year ago . India's Wockhardt Ltd - March-quarter consol net sales 10.13 billion rupees versus 10.79 billion rupees year ago .  Full Article

More From Around the Web

BRIEF-KPC Pharma to signs MOU with Swiss firm Wockhardt on sales of insulin related products in China

* Says it plans to signs MOU with Switzerland's Wockhardt on sales of insulin-related products in China